• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1200051 戈利木单抗注射液 golimumab Injection Biological Products Import Drug Application 2012-07-09 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2014-07-24 view
JXSS1400007 CNTO 148单抗注射液 golimumab Injection Biological Products Import Drug Application 2014-07-17 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2018-01-04 view
JXSR1400001 戈利木单抗注射液 golimumab Injection Biological Products State Standards 2014-09-25 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2018-04-25 view
JYSB1600195 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2016-09-28 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2016-11-18 view
JYSB1700005 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2017-01-22 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2017-05-25 view
JYSB1700012 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2017-02-17 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2018-12-04 view
JYSB1700095 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2017-05-15 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2017-07-21 view
JYSB1800033 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2018-03-02 Janssen Biologics B.V. Janssen Biologics BV Filed 2018-03-18 view
JYSB1800120 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2018-06-04 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2018-07-26 view
JYSB1800138 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2018-07-09 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2019-02-22 view
JYSB1800200 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2018-09-29 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2019-05-06 view
JYSB1900061 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2019-03-11 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2019-05-17 view
JYSB1900121 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2019-05-31 Janssen Biologics B.V. Janssen Biologics BV Filed 2019-06-11 view
JYSB1900115 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2019-06-03 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2020-02-27 view
JYSB1900127 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2019-06-24 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2020-02-26 view
JYSB1900231 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2019-09-04 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2020-08-18 view
JYSB1900332 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2019-11-29 Janssen Biologics B.V. Janssen Biologics BV Filed 2019-12-10 view
JYSB2000030 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2020-02-19 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2020-04-23 view
JYSB2000149 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2020-05-09 Janssen Biologics B.V. Janssen Biologics BV In Review 2020-05-08 view
JYSB2000192 注射用英夫利西单抗 infliximab Lyophilized Biological Products Supplementary Application 2020-05-23 Janssen Biologics B.V. Janssen Biologics BV In Review 2020-05-22 view